See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Botox Treatments
Generic Name: Botulinum Toxin Type A
What is Botulinum Toxin Type A? Botulinum Toxin Type A is a neuromuscular blocker age. It is used to treat various types of dystonia (neurological movement disorders); for blepharospasm and strabismus; for primary axillary hyperhidrosis (excessive perspiration); and it is also used for cosmetic purposes.
See more information, including instructions, precautions, side effects, and interactions.
50 patients in the community are taking or have taken Botulinum Toxin Type A.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Other | 18 | 36% |
| Stiffness/spasticity | 10 | 20% |
| Bladder problems | 6 | 12% |
| Disordered muscle tension (dystonia) | 2 | 4% |
| Foot drop | 2 | 4% |
| Muscle spasms, neck and shoulders | 1 | 2% |
| Head tremors | 1 | 2% |
| Facial tics | 1 | 2% |
| spasms/shocks in legs | 1 | 2% |
| Headaches/ Migraines | 1 | 2% |
| Cramps, feet | 1 | 2% |
| Excessive daytime sleepiness (somnolence) | 1 | 2% |
| Support another treatment | 1 | 2% |
| foot dystonia | 1 | 2% |
| General health | 1 | 2% |
| Treat Parkinson's | 1 | 2% |
Based on the patients currently taking Botulinum Toxin Type A.
Top 10 (Show all)
All (Show Top 10)
| 0 intl units As needed | 0 As needed | 0 intl units Monthly | 20 other As needed | 100 units All the time (24/7) | 100 units As needed | 175 intl units As needed | 200 intl units As needed | 300 intl units As needed | 5 intl units Yearly | 200 intl units Monthly | 200 intl units As needed | 25000 units Yearly | 100 units Daily | 200 intl units One time | 400 units As needed | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6
|
1
|
1
|
1
|
1
|
5
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
||
How long current patients have been taking Botulinum Toxin Type A or how long patients were taking Botulinum Toxin Type A before stopping.
Results from 9 patient evaluations. See the overall results and all individual evaluations.
| Major | 33% | 1 |
|---|---|---|
| Moderate | 33% | 1 |
| Slight | 33% | 1 |
Other
| Severe | 11% | 1 |
|---|---|---|
| Moderate | 11% | 1 |
| Mild | 0% | 0 |
| None | 78% | 7 |
Top reported side-effects include: Numbness, Pain during Injection
Summary results are based on 9 individual responses. For more information, see overall results for Adherence, Burden and Cost.